Sunday 22 May, 12.30-13.45
Diabetes, Obesity and Atherosclerosis- New Horizons in ASCVD Prevention
This activity has been supported by an educational grant from Novo Nordisk
Sunday 22 May, 14.00-15.15
Implementation of the 2019 lipid guidelines-where are we now?
This activity has been supported by an educational grant from Daiichi
Sunday 22 May, 15.30-16.45
Omega 3 fatty acids in cardiovascular prevention – Where do we stand?
This activity has been supported by an educational grant from Amarin
Sunday 22 May, 17.00-18.15
Reimagining population health-the time is now
This activity has been supported by an educational grant from Novartis
Monday 23 May, 13.30-14.45
Why and how to implement early combination lipid lowering therapy
This activity has been supported by an educational grant from Sanofi
Monday 23 May, 14.45-15.30
HOFH: new insights in therapeutic approaches
This activity has been supported by an educational grant from Ultragenyx
Tuesday 24 May, 13.30-14.45
Debate: Who needs injectable therapies for cholesterol lowering? Statins and ezetimibe are enough for CVD prevention
This activity has been supported by an educational grant from Viatris
Tuesday 24 May, 14.45-15.30
IME Session – Should public health recommendations target Lp(a) measurements?
This activity has been supported by an educational grant from Novartis Pharma AG
